%0 Journal Article
%T Overexpression of TSPAN8 in consensus molecular subtype 3 colorectal cancer.
%A Suwatthanarak T
%A Tanjak P
%A Chaiboonchoe A
%A Acharayothin O
%A Thanormjit K
%A Chanthercrob J
%A Suwatthanarak T
%A Niyomchan A
%A Tanaka M
%A Okochi M
%A Pongpaibul A
%A Chalermwai WV
%A Trakarnsanga A
%A Methasate A
%A Pithukpakorn M
%A Chinswangwatanakul V
%J Exp Mol Pathol
%V 137
%N 0
%D 2024 Jun 10
%M 38861838
%F 4.401
%R 10.1016/j.yexmp.2024.104911
%X <B>BACKGROUND: </B>Recently, consensus molecular subtypes (CMSs) have been proposed as a robust transcriptome-based classification system for colorectal cancer (CRC). Tetraspanins (TSPANs) are transmembrane proteins. They have been associated with the development of numerous malignancies, including CRC, through their role as "master organizers" for multi-molecular membrane complexes. No previous study has investigated the correlation between TSPANs and CMS classification. Herein, we investigated the expression of TSPANs in patient-derived primary CRC tissues and their CMS classifications.<BR><B>METHODS: </B>RNA samples were derived from primary CRC tissues (n = 100 patients diagnosed with colorectal adenocarcinoma) and subjected to RNA sequencing for transcriptome-based CMS classification and TSPAN-relevant analyses. Immunohistochemistry (IHC) and immunofluorescence (IF) stains were conducted to observe the protein expression level. To evaluate the relative biological pathways, gene-set enrichment analysis was performed.<BR><B>RESULTS: </B>Of the highly expressed TSPAN genes in CRC tissues (TSPAN8, TSPAN29, and TSPAN30), TSPAN8 was notably overexpressed in CMS3-classified primary tissues. The overexpression of TSPAN8 protein in CMS3 CRC was also observed by IHC and IF staining. As a result of gene-set enrichment analysis, TSPAN8 may potentially play a role in organizing signaling complexes for kinase-based metabolic deregulation in CMS3 CRC.<BR><B>CONCLUSIONS: </B>The present study reports the overexpression of TSPAN8 in CMS3 CRC. This study proposes TSPAN8 as a subtype-specific biomarker for CMS3 CRC. This finding provides a foundation for future CMS-based studies of CRC, a complex disease and the second leading cause of cancer mortality worldwide.